DE3863859D1 - Stabile, injizierbare loesungen von salzen von vincristin. - Google Patents

Stabile, injizierbare loesungen von salzen von vincristin.

Info

Publication number
DE3863859D1
DE3863859D1 DE8888103072T DE3863859T DE3863859D1 DE 3863859 D1 DE3863859 D1 DE 3863859D1 DE 8888103072 T DE8888103072 T DE 8888103072T DE 3863859 T DE3863859 T DE 3863859T DE 3863859 D1 DE3863859 D1 DE 3863859D1
Authority
DE
Germany
Prior art keywords
salts
stable
vincristin
injectable solutions
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888103072T
Other languages
English (en)
Inventor
Rodney Kasan
Michael Seiffe
Haim Yellin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of DE3863859D1 publication Critical patent/DE3863859D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
DE8888103072T 1987-07-06 1988-03-01 Stabile, injizierbare loesungen von salzen von vincristin. Expired - Lifetime DE3863859D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL83086A IL83086A (en) 1987-07-06 1987-07-06 Stable,injectable solutions of vincristine salts

Publications (1)

Publication Number Publication Date
DE3863859D1 true DE3863859D1 (de) 1991-08-29

Family

ID=11057953

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888103072T Expired - Lifetime DE3863859D1 (de) 1987-07-06 1988-03-01 Stabile, injizierbare loesungen von salzen von vincristin.

Country Status (8)

Country Link
US (1) US4883805A (de)
EP (1) EP0298192B1 (de)
JP (1) JPS6416724A (de)
AT (1) ATE65401T1 (de)
CA (1) CA1303992C (de)
DE (1) DE3863859D1 (de)
ES (1) ES2028917T3 (de)
IL (1) IL83086A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU204995B (en) * 1989-11-07 1992-03-30 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
DE19818802A1 (de) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stabile Mitoxantron-Lösungen
AU2001256714A1 (en) 2000-05-15 2001-11-26 Kissei Pharmaceutical Co. Ltd. Water-based liquid preparation
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
PL2368553T3 (pl) 2003-04-08 2015-05-29 Progenics Pharm Inc Preparaty farmaceutyczne zawierające metylonaltrekson
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
US7923037B2 (en) * 2006-10-05 2011-04-12 Ikaria, Inc. Liquid chalcogenide compositions and methods of manufacturing and using the same
JP6099557B2 (ja) * 2013-12-27 2017-03-22 富士フイルム株式会社 注射液製剤及びその製造方法
US11058679B2 (en) 2015-08-01 2021-07-13 Sun Pharmaceutical Industries Ltd. Dosage form of vinca alkaloid drug
CN114699369A (zh) * 2022-05-19 2022-07-05 青岛农业大学 一种盐酸溴己新注射液及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248291A (en) * 1963-08-19 1966-04-26 Hoffmann La Roche Stabilized thioxanthene derivatives and method of using the same
GB1254057A (en) * 1969-04-24 1971-11-17 Louisette Olivier Improvements in or relating to therapeutical composition containing vincamine
GB2020180B (en) * 1978-05-08 1982-08-25 Nelson Res & Dev Ophthalmic compositions containingcolchicine or vinblastinr
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US4708962A (en) * 1984-12-17 1987-11-24 Harbor Branch Oceanographic Institution, Inc. Antiviral and antitumor cyclohexadienone compositions
US4707498A (en) * 1986-01-14 1987-11-17 Merrell Dow Pharmaceuticals Inc. Fluorinated diaminoalkyne derivatives

Also Published As

Publication number Publication date
EP0298192A1 (de) 1989-01-11
CA1303992C (en) 1992-06-23
IL83086A0 (en) 1987-12-31
ES2028917T3 (es) 1992-07-16
AU604094B2 (en) 1990-12-06
IL83086A (en) 1991-03-10
US4883805A (en) 1989-11-28
AU1257888A (en) 1989-01-12
EP0298192B1 (de) 1991-07-24
ATE65401T1 (de) 1991-08-15
JPH0525857B2 (de) 1993-04-14
JPS6416724A (en) 1989-01-20

Similar Documents

Publication Publication Date Title
DZ1067A1 (fr) Nouvelles préparations pharmaceutiques à emission prolongée.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DE3863859D1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
DE69111205T2 (de) Stabilisierung von Calcitonin enthaltenden pharmazeutischen Verbindungen.
FR2681863B1 (fr) Solution de sparfloxacine sa preparation et sel la constituant.
NO902488L (no) Karboplatinapreparat.
AR245591A1 (es) Una composicion oral estable, con propiedades antiplaca y antigingivales mejoradas.
DK443988A (da) Injektionspraeparat indeholdende modificeret tpa
DE69016087D1 (de) Stabile Lösungen von Rebeccamycinderivaten sowie deren Herstellung.
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
ATE31623T1 (de) Injizierbare zusammensetzungen von bbm-928a.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee